INR matters: a case on managing argatroban for bridging oral anticoagulation in a patient with heparin induced thrombocytopenia type II after mechanical heart valve replacement

Thromb Res. 2009 Jun;124(2):242-3. doi: 10.1016/j.thromres.2008.08.023. Epub 2008 Nov 18.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Aortic Valve / surgery
  • Arginine / analogs & derivatives
  • Female
  • Heart Valve Prosthesis Implantation
  • Heparin / adverse effects*
  • Humans
  • International Normalized Ratio
  • Pipecolic Acids / adverse effects
  • Pipecolic Acids / therapeutic use*
  • Sulfonamides
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / classification
  • Thrombocytopenia / drug therapy*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Pipecolic Acids
  • Sulfonamides
  • Heparin
  • Arginine
  • argatroban